ALMDT Median Technologies SA

4.716USD4.300 EUR · EPA+2.38%Mkt Cap: 227.86M USDP/E: —

Median Technologies SA develops and markets software solutions and services for the use of medical images for the diagnosis and monitoring of patients with cancer in Europe, North America, and Asia. The company offers iC…

Key Statistics

Company
Market Cap227.86M USD
Enterprise Value189.37M USD
Revenue (TTM)26.18M USD
Gross Profit26.38M USD
Net Income (TTM)-37.37M USD
Revenue/Share0.50 USD
Last Price4.716 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees200
CountryFR
SectorHealthcare
IndustryMedical Devices
ISINFR0011049824
Valuation
P/E (Trailing)—
P/E (Forward)-19.72
PEG—
EV/EBITDA-7.78
EV/Revenue7.23
P/S8.70
P/B-74.39
EPS (TTM)-1.11 USD
EPS (Forward)-0.24 USD
52W Range
3.01634% of range7.974
52W High7.974 USD
52W Low3.016 USD
Profitability
Gross Margin102.98%
Oper. Margin-101.49%
EBITDA Margin-92.93%
Profit Margin-145.85%
ROE96.92%
ROA-94.97%
ROIC—
ROCE—
Growth
Revenue Growth3.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-19.11M USD
CapEx (TTM)819.31K USD
FCF Margin86.52%
FCF Yield9.94%
Net Debt-38.27M USD
Net Debt/EBITDA1.57
Net Debt/FCF-1.69
Balance Sheet
Debt/Equity-0.62
Current Ratio1.34
Quick Ratio1.31
Book Value/Sh-0.06 USD
Cash/Share1.37 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)13.13 USD
Upside (mean)+178.3%
Target Range10.97 USD – 15.36 USD
10.97+178.3% to mean15.36
# Analysts3
Ownership
Shares Out.49.00M
Float39.16M
Insiders26.54%
Institutions11.83%
Technical
SMA 504.241 (+11.2%)
SMA 2004.965 (-5.0%)
Beta0.57
S&P 52W Chg12.00%
Avg Vol (30d)134.29K
Avg Vol (10d)131.13K
Technical Indicators
RSI (14)58.7
MACD0.0917
MACD Signal0.0407
MACD Hist.+0.0510
BB Upper5.080 USD
BB Middle4.381 USD
BB Lower3.681 USD
BB Width31.94%
ATR (14)0.2604 USD
Vol Ratio (20d)0.64x

About Median Technologies (EPA: ALMDT)

›

Median Technologies (EPA: ALMDT) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 200 employees.

The shares were at 4.300 EUR on 19 November 2026, up 52.8% over 52 weeks. Its 52-week range is 2.750 EUR to 7.270 EUR: the price is 40.9% below the high and 56.4% above the low.

Its market capitalisation is 207.75M EUR.

Median Technologies reports return on equity of 96.9%, an operating margin of -101.5% and revenue up 3.5% year over year.

It holds more cash than debt, a net cash position of 34.89M EUR. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 3 analysts cover the stock; their mean price target of 11.97 EUR is 178.3% above the current price.